Thompson Siegel & Walmsley’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Thompson Siegel & Walmsley’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-225	Closed	-$20K	–	742
2021 Q3	$20K	Hold	225	–	–	﹤0.01%	580
2021 Q2	$20K	Hold	225	–	–	﹤0.01%	606
2021 Q1	$17K	Hold	225	–	–	﹤0.01%	598
2020 Q4	$15K	Hold	225	–	–	﹤0.01%	581
2020 Q3	$12K	Sell	225 -2	-0.9%	-$119	﹤0.01%	572
2020 Q2	$13K	Sell	227 -125,852	-100%	-$6.76M	﹤0.01%	567
2020 Q1	$4.97M	Sell	126,079 -81,344	-39%	-$4.76M	0.12%	141
2019 Q4	$12.3M	Sell	207,423 -15,548	-7%	-$836K	0.19%	111
2019 Q3	$11.9M	Sell	222,971 -37,130	-14%	-$1.91M	0.19%	109
2019 Q2	$13.3M	Buy	260,101 +38,264	+17%	+$1.78M	0.19%	107
2019 Q1	$11.5M	Sell	221,837 -80,149	-27%	-$3.89M	0.16%	121
2018 Q4	$11.9M	Sell	301,986 -45,000	-13%	-$2.09M	0.19%	117
2018 Q3	$17.9M	Buy	346,986 +22,947	+7%	+$1.12M	0.23%	106
2018 Q2	$15.2M	Sell	324,039 -220,086	-40%	-$9.11M	0.2%	115
2018 Q1	$19.3M	Buy	544,125 +229,260	+73%	+$8.98M	0.24%	111
2017 Q4	$13.7M	Buy	314,865 +19,516	+7%	+$912K	0.16%	140
2017 Q3	$15.4M	Buy	+295,349	New	+$16.5M	0.19%	135
2017 Q2	–	Sell	-19	Closed	-$1K	–	909
2017 Q1	$1K	Buy	+19	New	+$945	﹤0.01%	833

Other funds holding SYNH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Thompson Siegel & Walmsley's SYNH Position: Q4 2021 in Review

Thompson Siegel & Walmsley sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2021, closing a stake of 225 shares — an estimated $20K sold.

Thompson Siegel & Walmsley first reported a position in SYNH in Q1 2017 and held it in 18 quarters. The position peaked at $19.3M in Q1 2018. 377 funds tracked by Wall St. Rank hold SYNH as of Q4 2021.

Thompson Siegel & Walmsley reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
Thompson Siegel & Walmsley sold 225 Syneos Health, Inc. Class A Common Stock shares in Q4 2021, an estimated $20K.
Thompson Siegel & Walmsley first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2017 and held it in 18 quarters.
Thompson Siegel & Walmsley's Syneos Health, Inc. Class A Common Stock position peaked at $19.3M in Q1 2018.
377 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2021.

Based on Thompson Siegel & Walmsley's 13F filing for Q4 2021, filed 9 Feb 2022.